Advertisement for orthosearch.org.uk
Results 1 - 2 of 2
Results per page:
Applied filters
Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 279 - 279
1 Sep 2012
Lustig S Barba N Servien E Fary C Demey G Neyret P
Full Access

To our knowledge in medial unicompartmental knee arthroplasty (UKA) no study has specifically assessed the difference in outcome between matched gender groups. Previous unmatched gender studies have indicated more favourable results for women.

Method

2 groups of 40 of either sex was determined sufficient power for significant difference. These consecutively were matched with both the pre-operative clinical and radiological findings. Minimum follow up of 2 years, mean follow-up 5.9 years. Mean age at operation was 71 years.

Results

In both groups, the mean IKS knee and function scores improved significantly (p< 0.001) post operatively. There were no significant differences were between the 2 groups. In both groups mean preoperative flexion was 130 degrees and remained unchanged at final follow-up. No significant differences in preoperative and postoperative axial alignment and in the number of radiolucent lines, between groups.

With component size used there was a significant difference (p < 0.001) between the 2 groups. However the size of the femoral or tibial implant used was significantly related (p< 0.001) to patient height for both sexes. Radiolucent lines were more frequent on the tibial component, but were considered stable with none progressing. No revisions for component failure. 1 patient in each group developed lateral compartment degenerative change.

Male group; one conversion to TKA for undiagnosed pain, three patients underwent reoperation without changing the implant. Female group; no implants were revised, and two patients required a reoperation. Kaplan-Meier 5-year survival rate of 93.46% (84.8; 100) for men and100% for women. The survival rate difference is not significant (p=0.28).


Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_II | Pages 300 - 300
1 May 2010
Hamadouche M Biau D Barba N Musset T Gaucher F Chaix O Courpied J Langlais F
Full Access

Introduction: Although a number of methods have been described to treat recurrent dislocation following total hip arthroplasty, this complication remains a challenging problem. The purpose of this retrospective study was to evaluate the minimum 2-year outcome in a consecutive series patients treated with a cemented tripolar unconstrained acetabular component for recurrent dislocation.

Patients and Methods: Fifty-one patients presenting with recurrent dislocation following primary or revision total hip arthroplasty in the absence of an identifiable curable cause were treated with a cemented tripolar unconstrained acetabular component. There were thirty-nine females and twelve males with a mean age at the time of the index procedure of 71.3 years. A single acetabular component design was used consisting of a stainless steel outer shell with grooves for cement fixation with a highly polished inner surface. This shell articulated with a mobile intermediate component with an opening diameter smaller than the 22.2-mm femoral head. No locking ring or other mean of constraint was associated.

Results: Of the fifty-one patients, forty-seven have had complete clinical and radiological evaluation data at a mean follow-up of 31.2 months (twenty-four to 56.3 months). The cemented unconstrained tripolar acetabular component restored complete stability of the hip in forty-nine patients (96%). The mean Merle d’Aubigné hip score was 15.8 ± 2.0 at the latest follow-up. Radiographic analysis revealed no or radiolucent lines less than 1 mm thick located in a single acetabular zone in forty-three of forty-seven hips (91.5%). The cumulative survival rate of the acetabular component at 36 months using revision for dislocation and/or mechanical failure as the end point was 93.3 ± 4.6% (95% confidence interval, 84.4% to 100%).

Conclusion: A cemented tripolar unconstrained acetabular component was highly effective in the treatment of recurrent dislocation with none of the complications associated with constrained devices. However, because longer term follow-up is needed to warrant that dislocation and loosening rates will not increase, the use of such a device should be limited to strict indications.